(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 106.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.17%.
Scholar Rock Holding's revenue in 2025 is $0.On average, 15 Wall Street analysts forecast SRRK's revenue for 2025 to be $356,439,899, with the lowest SRRK revenue forecast at $0, and the highest SRRK revenue forecast at $2,220,539,822.  On average, 15 Wall Street analysts forecast SRRK's revenue for 2026 to be $7,441,211,584, with the lowest SRRK revenue forecast at $744,313,413, and the highest SRRK revenue forecast at $13,323,238,929.  
In 2027, SRRK is forecast to generate $26,280,232,978 in revenue, with the lowest revenue forecast at $15,072,755,152 and the highest revenue forecast at $39,767,849,531.